The whole slide imaging market in Asia Pacific is expected to grow from US$ 110.48 million in 2022 to US$ 309.94 million by 2028. It is estimated to grow at a CAGR of 18.8% from 2022 to 2028.
Telemedicine technologies incorporate the utilization of modern communication platforms intending to conduct virtual interaction between patients and healthcare professionals. Moreover, the technology deals with the evaluation, diagnosis, and treatment of patients with the help of telecommunication technologies. The adoption of telemedicine technologies allows the physician and patient to communicate over geographical boundaries. Digital pathology in whole slide imaging offers a significant way for image archiving and comprehensive analysis with the help of intelligent algorithms, allowing healthcare professionals to access and study images anywhere, anytime. This prominent benefit served by telemedicine technologies and growing investments are likely to offer lucrative growth opportunity for the market during the forecast period.
Companies are focusing on the establishment of partnerships and collaborations in order to consolidate the reach of tele-health or remote pathology consultations. As, whole slide imaging enables image archive and sharing facility, the systems are expected to witness considerable demand in the near future. For instance, in February 2019, the collaboration of OptraSCAN and Neuberg Diagnostics announced launch of joint-ventured telepathology network in the UAE and South Africa. The collaboration emphasizes on serving advanced digital pathology-based solutions for better diagnostic outcomes. Further, companies are emphasizing on introduction of new technologies in order to deal complexities in telepathology. For instance, in August 2020, Motic Digital Pathology launched a cloud-based global telepathology platform for scanning and viewing of whole slide images from remote locations. Increasing number of developments in telemedicine technologies is projected to offer a lucrative growth opportunity for the market by 2027.
In March 2020, Medmain launched its AI-based digital pathology system, PidPort. The system is equipped with advanced algorithms and whole slide imaging technology for comprehensive cell-based analysis. Additionally, in June 2020, HAMAMATSU Photonics K.K. Systems launched its new remote diagnostics and digital pathology platform to operate during the pandemic period. The platform incorporates whole slide imaging, offering opportunity for pathologists to work from home. Such benefits of whole slide imaging are likely to accelerate the adoption of whole slide imaging, which will in turn drive the growth of Japan whole slide imaging market during the forecast period.
Growing number of funding and investments in Japan market are also one of the prominent factors contributing to the market growth. For instance, in August 2020, Medmain, one of the significant players in the healthcare telecommunication market raised around US$ 10.0 Mn for the expansion of AI-powered telepathology diagnostic system. Such investments are estimated to offer lucrative opportunity for the market growth over study period.
Telemedicine technologies incorporate the utilization of modern communication platforms intending to conduct virtual interaction between patients and healthcare professionals. Moreover, the technology deals with the evaluation, diagnosis, and treatment of patients with the help of telecommunication technologies. The adoption of telemedicine technologies allows the physician and patient to communicate over geographical boundaries. Digital pathology in whole slide imaging offers a significant way for image archiving and comprehensive analysis with the help of intelligent algorithms, allowing healthcare professionals to access and study images anywhere, anytime. This prominent benefit served by telemedicine technologies and growing investments are likely to offer lucrative growth opportunity for the market during the forecast period.
Companies are focusing on the establishment of partnerships and collaborations in order to consolidate the reach of tele-health or remote pathology consultations. As, whole slide imaging enables image archive and sharing facility, the systems are expected to witness considerable demand in the near future. For instance, in February 2019, the collaboration of OptraSCAN and Neuberg Diagnostics announced launch of joint-ventured telepathology network in the UAE and South Africa. The collaboration emphasizes on serving advanced digital pathology-based solutions for better diagnostic outcomes. Further, companies are emphasizing on introduction of new technologies in order to deal complexities in telepathology. For instance, in August 2020, Motic Digital Pathology launched a cloud-based global telepathology platform for scanning and viewing of whole slide images from remote locations. Increasing number of developments in telemedicine technologies is projected to offer a lucrative growth opportunity for the market by 2027.
Market Overview
Asia Pacific is fastest growing market for whole slide imaging in a global scenario. Japan is the major contributors to the growth of the market which is driven by rapidly developing healthcare infrastructure. Increasing number of product launches and introductions are expected to contribute to the growth of the Japan whole slide imaging market during the forecast period.In March 2020, Medmain launched its AI-based digital pathology system, PidPort. The system is equipped with advanced algorithms and whole slide imaging technology for comprehensive cell-based analysis. Additionally, in June 2020, HAMAMATSU Photonics K.K. Systems launched its new remote diagnostics and digital pathology platform to operate during the pandemic period. The platform incorporates whole slide imaging, offering opportunity for pathologists to work from home. Such benefits of whole slide imaging are likely to accelerate the adoption of whole slide imaging, which will in turn drive the growth of Japan whole slide imaging market during the forecast period.
Growing number of funding and investments in Japan market are also one of the prominent factors contributing to the market growth. For instance, in August 2020, Medmain, one of the significant players in the healthcare telecommunication market raised around US$ 10.0 Mn for the expansion of AI-powered telepathology diagnostic system. Such investments are estimated to offer lucrative opportunity for the market growth over study period.
Asia Pacific Whole Slide Imaging Market Segmentation
The Asia Pacific whole slide imaging market is segmented into type, application, end user, and country.- Based on type, the market is segmented into hardware, software, and services. The hardware segment registered the largest market share in 2022.
- Based on application, the market is segmented into telepathology, cytopathology, immunohistochemistry, and hematopathology. The telepathology segment held a larger market share in 2022.
- Based on end user, the market is segmented into academic research institutes, hospitals, pharmaceutical and biopharmaceutical companies, and laboratories. The academic research institutes segment held the largest market share in 2022.
- Based on country, the market is segmented into Japan, China, India, South Korea, Australia, and Rest of APAC. Japan dominated the market share in 2022.
Table of Contents
1. Introduction
3. Research Methodology
4. Asia Pacific Whole Slide Imaging Market Landscape
5. Asia Pacific Whole Slide Imaging Market - Key Market Dynamics
6. Asia pacific Whole Slide Imaging Market Analysis
7. Asia pacific Whole Slide Imaging Market Analysis - By Type
8. Asia Pacific Whole Slide Imaging Market Analysis - By Application
9. Asia Pacific Whole Slide Imaging Market - By End User
10. Asia Pacific Slide Imaging Market - Country Analysis
11. Asia Pacific Whole Slide Imaging Market - Industry Landscape
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned
- 3DHISTECH Ltd.
- Hamamatsu Photonics K.K.
- Indica Labs
- Inspirata Inc.
- Leica Biosystems Nussloch GmbH (Danaher)
- Nikon Corporation
- Olympus Corporation
- Visiopharm A/S
- Akoya Biosciences, Inc.
- Koninklijke Philips N.V.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 157 |
| Published | October 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 110.48 Million |
| Forecasted Market Value ( USD | $ 309.94 Million |
| Compound Annual Growth Rate | 18.8% |
| Regions Covered | Asia Pacific |
| No. of Companies Mentioned | 10 |
